| Symbol | Sector | Firm | Action | Grade | Target | Mkt Cap ▼ | Base | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AVGO | Technology | B. Riley FBR | Maintains | Buy → Buy | — | $2.0T | $13.25 | +1.3% | +0.5% | +0.7% | +3.3% | -1.0% | +0.2% |
| AVGO | Technology | B. Riley | Maintains | Buy → Buy | — | $2.0T | $13.25 | +1.3% | +0.5% | +0.7% | +3.3% | -1.0% | +0.2% |
| COST | Consumer Defensive | Cleveland Research | Downgrade | Buy → Neutral | — | $486.8B | $154.72 | -1.1% | -3.3% | +0.2% | +0.3% | +1.5% | -0.8% |
| KO | Consumer Defensive | Sterne Agee CRT | Downgrade | Buy → Neutral | — | $353.3B | $44.16 | -0.3% | -2.3% | -0.0% | +1.3% | +0.2% | +0.4% |
| KO | Consumer Defensive | Sterne Agee | Downgrade | Buy → Neutral | — | $353.3B | $44.16 | -0.3% | -2.3% | -0.0% | +1.3% | +0.2% | +0.4% |
| PEP | Consumer Defensive | Sterne Agee | Downgrade | Buy → Neutral | — | $206.5B | $100.67 | -0.2% | -2.3% | -0.5% | +1.3% | -0.8% | +0.8% |
| PEP | Consumer Defensive | Sterne Agee CRT | Downgrade | Buy → Neutral | — | $206.5B | $100.67 | -0.2% | -2.3% | -0.5% | +1.3% | -0.8% | +0.8% |
| PANW | Technology | BofA SecuritiesA | Upgrade | Neutral → Buy | — | $170.3B | $23.38 | +6.8% | +5.2% | -1.9% | +2.7% | -0.3% | +2.6% |
| PANW | Technology | Barclays | Maintains | Overweight → Overweight | — | $170.3B | $23.38 | +6.8% | +5.2% | -1.9% | +2.7% | -0.3% | +2.6% |
| PANW | Technology | FBR Capital | Maintains | Outperform → Outperform | — | $170.3B | $23.38 | +6.8% | +5.2% | -1.9% | +2.7% | -0.3% | +2.6% |
| INTU | Technology | RBC Capital | Maintains | Sector Perform → Sector Perform | — | $113.1B | $100.07 | +0.8% | -4.3% | +0.9% | +2.3% | -0.2% | -0.9% |
| INTU | Technology | UBS | Maintains | Buy → Buy | — | $113.1B | $100.07 | +0.8% | -4.3% | +0.9% | +2.3% | -0.2% | -0.9% |
| GSK | Healthcare | Cantor Fitzgerald | Maintains | Hold → Hold | — | $105.1B | $39.50 | -0.5% | -0.9% | -1.2% | +2.6% | -0.7% | -0.6% |
| MNST | Consumer Defensive | CLSA | Maintains | Outperform → Buy | — | $85.0B | $22.18 | -4.0% | -1.7% | -4.0% | +3.3% | -1.5% | +0.6% |
| CL | Consumer Defensive | Sterne Agee | Downgrade | Buy → Neutral | — | $73.0B | $67.42 | -0.3% | -1.7% | -1.0% | +2.6% | -0.4% | +0.8% |
| CL | Consumer Defensive | Sterne Agee CRT | Downgrade | Buy → Neutral | — | $73.0B | $67.42 | -0.3% | -1.7% | -1.0% | +2.6% | -0.4% | +0.8% |
| TRGP | Energy | Credit SuisseB | Upgrade | Underperform → Neutral | — | $59.4B | $24.30 | +3.0% | +5.1% | +5.2% | -1.6% | +2.8% | +5.7% |
| ADSK | Technology | Barclays | Maintains | Overweight → Overweight | — | $52.4B | $49.42 | +3.1% | +3.6% | +1.1% | +5.0% | +0.2% | +0.7% |
| ADSK | Technology | UBS | Maintains | Neutral → Neutral | — | $52.4B | $49.42 | +3.1% | +3.6% | +1.1% | +5.0% | +0.2% | +0.7% |
| ADSK | Technology | Credit Suisse | Maintains | Outperform → Outperform | — | $52.4B | $49.42 | +3.1% | +3.6% | +1.1% | +5.0% | +0.2% | +0.7% |